Companies / France
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Regulations Force Sanofi-Aventis To Restructure
October 2006 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Because of cost-cutting measures imposed by domestic regulators, French firm Sanofi-Aventis - Europe's leading pharmaceutical company - is to eliminate 500 jobs at its headquarters. Simultaneously, the country's Health Minister has decided against removing a selection of medicines from the reimbursement list, instead enforcing 20% price cuts or lower reimbursement rates for the products. BMI views both developments as typical for Western Europe, where governments are desperately trying to control rising healthcare costs and companies are constantly looking at ways to remain